Related Experiment Video
Updated: Feb 15, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Virulence Factors as Targets for Anticryptococcal Therapy
Renata V D M Azevedo1, Juliana Rizzo2,3, Marcio L Rodrigues4,5
1Fundação Oswaldo Cruz-Fiocruz, Centro de Desenvolvimento Tecnológico em Saúde (CDTS), 21040-361 Rio de Janeiro, Brazil. razevedo@cdts.fiocruz.br.
Abstract:
The global mortality due to cryptococcosis caused by Cryptococcus neoformans or C. gattii is unacceptably high. Currently available therapies are decades old and may be impacted by drug resistance. Therefore, the need for more effective antifungal drugs for cryptococcosis is evident. A number of Cryptococcus virulence factors have been studied in detail, providing crucial information about the fungal biology and putative molecular targets for antifungals. This review focuses on the use of well-described virulence factors of Cryptococcus as potential anticryptococcal agents.
Insights
High mortality from cryptococcosis necessitates new antifungal drugs. This review explores using Cryptococcus virulence factors as novel therapeutic targets to combat drug resistance and improve treatment outcomes.
Area of Science:
- Mycology
- Infectious Diseases
- Pharmacology
Background:
- Cryptococcosis, caused by Cryptococcus neoformans and Cryptococcus gattii, results in high global mortality.
- Current antifungal therapies are outdated and face challenges with emerging drug resistance.
- There is a critical need for novel and effective treatments against cryptococcosis.
Purpose of the Study:
- To review the potential of Cryptococcus virulence factors as targets for new antifungal drug development.
- To highlight the importance of understanding fungal biology for therapeutic innovation.
Main Methods:
- Literature review of studies on Cryptococcus virulence factors.
- Analysis of fungal biology and molecular targets for antifungal agents.
- Focus on well-characterized virulence factors with therapeutic potential.
Main Results:
- Detailed studies of Cryptococcus virulence factors provide insights into fungal pathogenesis.
- These factors represent promising molecular targets for novel anticryptococcal agents.
- Targeting virulence factors may offer alternative strategies to overcome drug resistance.
Conclusions:
- Virulence factors of Cryptococcus are viable targets for developing new antifungal therapies.
- Further research into these factors can lead to more effective treatments for cryptococcosis.
- Exploiting virulence factors is a promising strategy to address the unmet medical need in cryptococcosis treatment.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Gene Therapy
Transcription Factors
Group Therapy
Factors Affecting Solubility
Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...

